Rabavert rabies vacc w-diluents
Ended Awarded Last action
- Contract number
- SPE2DR26FFJ4D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,406
Award facts
- Contract value 100% obligated
- $28,406.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $28,406 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on December 22, 2025, for Rabavert rabies vaccine with diluents. The delivery order is scheduled for completion by December 23, 2025, and represents a competitive award with no set-aside designation. This contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle that runs through December 2026 and enables the company to supply pharmaceutical products and medical supplies to military healthcare systems worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills broad-spectrum pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Rabavert vaccine delivery supports military medical readiness by ensuring adequate rabies prophylaxis inventory. DLA Troop Support Medical, which manages pharmaceutical supply chains for the Department of Defense, has indicated plans to establish the Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among key strategic pharmaceutical suppliers within the federal healthcare ecosystem.
Quick answers
Who was awarded contract SPE2DR26FFJ4D?
SPE2DR26FFJ4D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FFJ4D worth?
The government has obligated $28,406 on SPE2DR26FFJ4D.
Is contract SPE2DR26FFJ4D an order under another contract?
Yes. SPE2DR26FFJ4D is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFJ4D competed?
The extent of competition for SPE2DR26FFJ4D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award